1. Home
  2. XYLO vs CYTO Comparison

XYLO vs CYTO Comparison

Compare XYLO & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • CYTO
  • Stock Information
  • Founded
  • XYLO 1999
  • CYTO 2003
  • Country
  • XYLO Israel
  • CYTO Bermuda
  • Employees
  • XYLO N/A
  • CYTO N/A
  • Industry
  • XYLO
  • CYTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • CYTO Health Care
  • Exchange
  • XYLO NYSE
  • CYTO Nasdaq
  • Market Cap
  • XYLO 2.2M
  • CYTO 2.2M
  • IPO Year
  • XYLO N/A
  • CYTO N/A
  • Fundamental
  • Price
  • XYLO $2.92
  • CYTO $0.46
  • Analyst Decision
  • XYLO
  • CYTO
  • Analyst Count
  • XYLO 0
  • CYTO 0
  • Target Price
  • XYLO N/A
  • CYTO N/A
  • AVG Volume (30 Days)
  • XYLO 21.9K
  • CYTO 106.0K
  • Earning Date
  • XYLO 11-29-2024
  • CYTO 09-24-2024
  • Dividend Yield
  • XYLO N/A
  • CYTO N/A
  • EPS Growth
  • XYLO N/A
  • CYTO N/A
  • EPS
  • XYLO N/A
  • CYTO N/A
  • Revenue
  • XYLO $57,642,000.00
  • CYTO N/A
  • Revenue This Year
  • XYLO N/A
  • CYTO N/A
  • Revenue Next Year
  • XYLO N/A
  • CYTO N/A
  • P/E Ratio
  • XYLO N/A
  • CYTO N/A
  • Revenue Growth
  • XYLO N/A
  • CYTO N/A
  • 52 Week Low
  • XYLO $2.70
  • CYTO $0.40
  • 52 Week High
  • XYLO $10.43
  • CYTO $17.20
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 41.43
  • CYTO 35.16
  • Support Level
  • XYLO $2.71
  • CYTO $0.40
  • Resistance Level
  • XYLO $3.13
  • CYTO $0.62
  • Average True Range (ATR)
  • XYLO 0.33
  • CYTO 0.06
  • MACD
  • XYLO -0.06
  • CYTO 0.00
  • Stochastic Oscillator
  • XYLO 16.56
  • CYTO 25.18

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About CYTO Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

Share on Social Networks: